Mark Klempner is a clinical research site located in Boston, Massachusetts, United States 02111.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
Mark Klempner has participated in 2 clinical trials.
Therapeutic areas: Lyme Disease.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mark Klempner has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mark Klempner has 2 clinical trials on record. Their work covers Lyme Disease.
Mark Klempner has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.